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Since the initial report in 1982 that *Escherichia coli* O157:H7 is associated with severe human disease, the serotype O157:H7 has assumed a position of dominance among enterohemorrhagic *E*. *coli* (EHEC) serotypes in North America responsible for global widespread outbreaks of severe gastrointestinal disease ([@B1], [@B2]). This lineage of Shiga toxin-producing *E. coli* (STEC) O157:H7 is non-sorbitol fermenting and β-glucuronidase negative and has evolved from an O55:H7 progenitor ([@B3], [@B4]). The isolation in 1975 of this *E. coli* O157:H7 strain, designated 2886-75, from an adult with hemorrhagic colitis (HC) ([@B5], [@B6]) predated the 1982 Oregon and Michigan hamburger-associated *E. coli* O157:H7 outbreaks ([@B6]). Since 1982, this serogroup has emerged as the dominant cause of EHEC infections in North America. Infections typically present with symptoms of bloody diarrhea coupled with severe abdominal pain ([@B5], [@B6]) but can rapidly progress to life-threatening complications, such as hemolytic uremic syndrome (HUS), HC, and central nervous system failure ([@B7]--[@B12]).

Genomic DNA was subjected to Illumina sequencing using paired-end libraries with 300-bp inserts on the HiSeq platform. The draft genome was assembled with Velvet assembler ([@B13], [@B14]), and the IGS Annotation Engine and Manatee were used for genome annotation and visualization ([@B15]). Availability of the high-quality genome sequence enabled the determination of the pathogenome virulence state ([@B16]) and phylogenomic grouping according to established genotypic classification methods using *in-silico* and experimental assays ([@B17]--[@B20]). PCR genotyping confirmed the *stx* genotype and determined the occupancy of both the *yehV* and *wrbA* bacteriophage insertion sites ([@B21]). Strain 2886-75 has an unusual genotype. Unlike the majority of *E. coli* O157:H7 recovered from humans in the United States ([@B22]--[@B24]), this isolate is *stx*~1~ positive and *stx*~2~ negative. The *yehV* site is occupied by the *stx*~1~ bacteriophage that is not stably integrated. Hence, the genomic architecture does not fit the emergence scenario typical of other human-pathogenic *E. coli* O157:H7 strains, and this isolate cannot be placed into clusters 1, 2, or 3 ([@B25]). However, this strain shows other typical genetic hallmarks of EHEC. Strain 2886-75 carries the lineage-specific virulence plasmid pO157 ([@B26], [@B27]), the T allele of the translocated intimin receptor (*tir*) (255 T\>A), and a chimeric polymorphic variant of repeat region 1 (RR1) with the absence of the repeat regions RR2 and RR3, placing strain 2886-75 closest to group 8 ([@B28]). Multilocus sequence typing (MLST) ([@B18]) based on the nucleotide sequences of 15 housekeeping genes revealed that 2886-75 exhibits allele combination 23.11 ([@B19]) and belongs to the sequence type 11 (ST11) and complex/ABD group ([@B18], [@B20]). Strain 2886-75 is a representative of lineage I ([@B17], [@B29]) and clade 3.16 ([@B30]). The genome sequence presented here will be a valuable resource in studying *E. coli* O157:H7 pathogenome evolution by comparing this isolate to the extant genotypes and will aid in the development of a higher-resolution phylogenomic framework for improved molecular-guided pathogen surveillance and outbreak investigations ([@B10], [@B11], [@B31]).

Nucleotide sequence accession number. {#h1}
-------------------------------------

This genome sequence is deposited in GenBank under the accession number [AVRR00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AVRR00000000). A bacterial strain culture is available from the Biodefense and Emerging Infections Research Resources Repository (<http://www.beiresources.org/>).
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